Home > Our expertise > Our people > Trust Board > Mr Tim Bennett

Mr Tim Bennett

Tim Bennett was appointed to the Trust Board in 2019 and is a Director of Avalia Immunotherapies.

Tim is an experienced senior executive and strategic advisor with extensive experience in the capital, commodity and financial markets in New Zealand, the United States, Australia and Asia.

His executive roles have included Chief Executive Officer of NZX from 2012–2017, and a Partner of Oliver Wyman and the Boston Consulting Group. He is also a director of Partners Life and AIX.